Simvastatin and Primaquine Identified as Potential Endometriosis Therapeutics via a Novel Epithelial-Stromal Assembloid Drug Screening Assay
Using human endometrial assembloids, researchers found that simvastatin and primaquine reversed key endometriosis-associated gene expression pathways, validating their potential as therapeutics for this estrogen-driven disorder.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study utilized a novel human epithelial-stromal assembloid model to evaluate the therapeutic potential of repurposed drugs for endometriosis, specifically focusing on simvastatin and primaquine. Researchers exposed immortalized cell lines and primary patient tissue to these agents, followed by mRNA sequencing to assess changes in gene expression pathways associated with disease pathology. The results indicated that simvastatin significantly reversed cytokine-cytok receptor interactions in both cell types, while primaquine counteracted oxidative stress pathways, findings that aligned with prior animal model data showing reduced pain behaviors. Despite limitations regarding sample size, the work demonstrates the utility of assembloids for validating drug mechanisms relevant to this condition. This paper is centrally about endometriosis — specifically the identification and mechanistic validation of simvastatin and primaquine as potential therapeutics using a new assembloid screening assay.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
2,471 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Advances in the diagnosis and management of endometriosis: A comprehensive review via openalex
- A transcriptomics-based computational drug repurposing pipeline identifies simvastatin and primaquine as therapeutics for endometriosis via openalex
- Cyclooxygenase-2 in Endometriosis via openalex
- Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability via openalex
- Endometriosis and adenomyosis unveiled through single-cell glasses via openalex
- Lipophilic statins inhibit growth and reduce invasiveness of human endometrial stromal cells via openalex
- Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium via openalex
- Medical Management of Endometriosis via openalex
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review via openalex
- Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets via openalex
- Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis via openalex
- Spheroids as a model for endometriotic lesions via openalex
- The SCID mouse: an experimental model for endometriosis via openalex
- W3205064505 via openalex
- W4380632905 via openalex
- W4392765049 via openalex
- W4405322491 via openalex
- W4412527309 via openalex
- W4413304817 via openalex
- W7134957016 via openalex
- W2957470019 via openalex
- W1996048503 via openalex
- W2005159615 via openalex
- W2068413946 via openalex
- W2121604817 via openalex
- W2128054164 via openalex
- W2137632714 via openalex
- W2517382837 via openalex
- W1969397621 via openalex
- W2965589450 via openalex
- W2978961112 via openalex
- W3005892426 via openalex
- W3198684516 via openalex
SciLite annotations
chemicals 15
organisms 4
Source provenance
- europepmc
- last seen: 2026-11-16T06:34:34.192714+00:00
- openalex
- last seen: 2026-11-16T06:03:07.005966+00:00
- pubmed
- last seen: 2026-11-16T06:04:59.865946+00:00
- scilite
- last seen: 2026-10-04T09:59:34.739275+00:00